Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin

Summary

The goal of the study is to demonstrate whether a switch from insulin therapy to an oral therapy with pioglitazone/glimepiride will lead to a deterioration of glycemic control (increase in HbA1c by more than 0.5 %) within a 6 month observation period.

Timeline

Start

2005-04

Primary completion

—

Completion

2007-04

Drugs

Indications